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Abstract 
Objective: Simultaneously assess the relationship between the family support perception and 
the intensity of hopelessness, depression, and anxiety symptoms in alcohol or drug dependent 
(AOD) patients and in non-AOD dependent control group (CON). Method: 60 patients who met the 
DSM-IV criteria for AOD dependence and 65 individuals with similar profile, but not dependent 
on AOD completed the Family Support Perception Inventory (FSPI), Beck Depression Inventory 
(BDI), Beck Anxiety Inventory (BAI), and Beck Hopelessness Scale (BHS). Results: Logistic 
regression analysis indicated that high scores in family autonomy (OR = 0.08), and low scores in 
hopelessness (OR = 0.64) were negatively correlated with AOD dependence. Individuals with high 
scores in BAI had higher probability (OR = 1.22) of belonging to the AOD group, as well as those 
who reported previous psychiatric treatment (OR = 68.91). Only in the AOD group the total FSPI 
scores presented significant correlation with depression, anxiety, and hopelessness. Conclusions: 
Individuals with AOD dependence and low scores of family support perception also presented high 
scores of depression, anxiety, and hopelessness, suggesting that FSPI scores could be a useful 
‘social marker’ of AOD dependence with psychiatric comorbidities. These data also reinforce the 
relevance of evaluating family support in AOD treatment planning.
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A baixa percepção de suporte familiar pode ser um “marcador social” da 
dependência de substâncias? 
Resumo 
Objetivo: Estudar as relações entre a percepção do suporte familiar e sintomas de desesperança, 
depressão e ansiedade em pacientes dependentes de álcool ou drogas (AOD) e um grupo-controle 
(CON). Método: Sessenta pacientes que preencheram critérios do DSM-IV para dependência de 
AOD e um grupo-controle com 65 indivíduos com perfil similar, mas não dependentes de AOD 
preencheram o inventário de Percepção de Suporte Familiar (IPSF), o Inventário de Depressão 
de Beck (BDI), o Inventário de Ansiedade de Beck (BAI) e a Escala de Desesperança de Beck 
(BHS). Resultados: Segundo a análise de regressão logística, altos escores de autonomia familiar 
(OR = 0,08) e baixos escores de desesperança (OR = 0,64) correlacionaram-se negativamente 
com ser dependente de AOD. Pessoas com altos escores no BAI apresentaram maior chance 
(OR = 1,22) de pertencer ao grupo AOD, assim como as que relataram já terem sido submetidas 
a tratamento psiquiátrico (OR = 68,91). Somente no grupo AOD os escores totais no IPSF se 
correlacionaram significativamente com sintomas de depressão, ansiedade e desesperança. 
Conclusões: Dependentes de AOD com baixa percepção de suporte familiar apresentaram 
também altos escores de depressão, ansiedade e desesperança, sugerindo que o IPSF poderia 
ser um útil “marcador social” da dependência de AOD associada a comorbidades psiquiátricas. 
Os dados reforçam a relevância de avaliar o suporte familiar no planejamento de tratamento 
para dependência de AOD. 
©2012 Elsevier Editora Ltda. Todos os direitos reservados.
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Approximately 200 million people use alcohol and other 
drugs.1 This high incidence of psychoactive substance use 
has been associated with several psychiatric disorders, par-
ticularly anxiety, depression, and other mood disorders, with 
major negative impact on the lives of substance dependent 
individuals.2,3,4
Furthermore, even “social drinkers” have shown higher 
incidence of depressive mood and anxiety than teetotalers.5,6 
Alcohol or drug use frequently triggers feelings of hopelessness 
and these sensations may facilitate the onset of depression 
or suicide attempts.7 In a recent review, Vijayakumar et al.8 
reported a significant association between substance use and 
suicide. They consider alcohol use disorder a distal risk factor 
for accomplished suicide and the use of other substances as a 
trigger for suicidal behavior. However, the direct influence of 
substances in suicidal behavior needs to be further explored. 
They also reported that psychiatric comorbidity with substance 
use increases the risk for suicidal behavior. Several other 
factors such as family dysfunction and life-cycle problems 
are also associated with psychiatric disorders and substance 
abuse risks. Therefore, it is important to evaluate these factors 
simultaneously, in order to estimate the specific contribution 
of each one4. Although the association between psychoactive 
substance use and mental health disorders is clear, the causal-
ity of this association is not clearly established.9,10
Individuals growing up in families lacking clear rules for 
the use of alcohol or drugs are at greater risk of substance 
abuse than those who do have clear rules.11,12 Moreover, poor 
family relationships, and low self-respect or self-esteem 
are among the triggering factors associated with alcohol 
abuse.13 On the other hand, the family can foster the learn-
ing of healthy behaviors and be a source of support for the 
treatment of individuals with problems due to alcohol or 
drug abuse.14 Family support can be demonstrated by the 
expression of caring, comfort, protection, interest, affec-
tion, and empathy among family members.15 Heavy users or 
dependents on alcohol or drugs frequently experience severe 
disorders in their family environments, which could be even 
worse if they also present psychiatric disorders.13,16
Some studies show that substance abuse can aggravate 
depression and increase the risk of suicide.17 Other studies 
indicate that substance use can also increase hopelessness 
and dissatisfaction feelings.18 There are some reports on low 
levels of family support as a risk factor for substance use.19 In 
spite of many studies showing the co-occurrence of family and 
psychiatric disorders in substance abusers, there is a paucity 
of studies on the relationship among them. To the best of our 
knowledge, this is the first controlled study in which these 
factors have been appraised simultaneously. The aim of this 
study was to evaluate and compare the perception of family 
support, feelings of hopelessness, and symptoms of depression 
and anxiety, as well as the relationship among these factors, 
in a sample of subjects with alcohol or drug dependence and in 
a control group of non-dependents. 
Methods
Participants
In the present study, we used a case-control design with 
sampling criteria. We invited individuals with alcohol and/
or other drug dependence (AOD group, N = 60) who had been 
admitted to treatment at least three months before in one 
out of five specialized services (two clinics exclusively for 
women and three exclusively for men) located in Santos (São 
Paulo, Brazil) to participate in the study. All of them met 
the DSM-IV criteria of the American Psychiatric Association3 
for alcohol or drug abuse or dependence confirmed by the 
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application of a symptom checklist. Before approaching pa-
tients, the researchers presented the project to the clinics’ 
managers and requested authorization to invite them. The 
recruitment of participants in the control group (N = 65) was 
made simultaneously in public settings (parks, gas stations, 
stores etc.) located in the same neighborhood, looking for 
individuals with similar social and demographic profile (re-
garding gender, age (18-59), education, and family income) 
who did not meet the DSM-IV criteria for alcohol or other 
drug dependence (checklist applied by a researcher).
Before participating, all volunteers or their guardians 
were informed on the objectives of the project, as well as 
on all procedures and any discomfort involving the evaluation 
process. All patients or volunteers signed the informed con-
sent to participate in this study. The study was approved by 
the Ethics Committee on Human Research of the Instituto de 
Psicologia, Universidade de Sao Paulo (IP-USP) (#3806/06) and 
conducted in strict adherence to the Declaration of Helsinki.
Instruments
The following instruments were used to collect data:
a) Questionnaire on social/demographic data and alco-
hol/drug consumption: Developed by the authors of this 
study, containing questions on age, gender, educational 
level, family income, and kind of drug used. 
b) Brazilian version of the Beck Depression Inventory 
(BDI) (validated by Cunha20): Used to evaluate the inten-
sity of depression symptoms, containing 21 items, with 
responses rated on a Likert scale. Scores range from 0 
to 63 points (0-11 minimal; 12-19 mild; 20-35 moderate; 
36-63 severe). The translated version used was validated 
for the Brazilian population and its Cronbach’s α was 
0.79 to 0.91 in psychiatric and non-psychiatric popula-
tions, respectively, which were similar to the ones in the 
original version (whose Cronbach’s α were 0.76 to 0.95, 
respectively).21 In our sample, the Cronbach’s α value 
was 0.95, which was very similar to that reported by the 
authors of the original instrument. 
c) Brazilian version of Beck Hopelessness Scale (BHS) 
(validated by Cunha20): Consisting of 20 items with 
true-or-false responses. Scores range from 0 to 20 (0-4 
minimal hopelessness; 5-8 mild hopelessness; 9-13 mod-
erate hopelessness; 14-20 severe hopelessness).20 The 
translated version used was validated for the Brazilian 
population and its Cronbach’s α was 0.85 in psychiatric 
and 0.77 in non-psychiatric populations, and similar to the 
ones in the original version whose Cronbach’s α were 0.90 
and 0.86, respectively.21 In our sample the Cronbach’s α 
value was 0.84, which was very similar to that reported 
by the authors of the original instrument.
d) Brazilian version of Beck Anxiety Inventory (BAI) (vali-
dated by Cunha20): Used to assess anxiety level, consisting 
of 21 statements, with responses rated on a Likert scale 
from 0 to 63 points (0-10: minimal anxiety; 11-19: mild 
anxiety; 20-30: moderate anxiety, and 31-63: severe anxi-
ety). The translated version used was validated for the 
Brazilian population with Cronbach’s α 0.92 in psychiatric 
populations and 0.90 in non-psychiatric populations, simi-
lar to the ones in the original version whose Cronbach’s 
α were respectively 0.90 and 0.86.20,21 In our sample the 
Cronbach’s α value was 0.87, which was very similar to 
that reported by the authors of the original instrument. 
Beck inventories present a good factorial structure as 
well as good internal consistency (reliability indicators) 
and are considered clinically valid.22,23
e) Family Support Perception Inventory (FSPI): Used to 
evaluate the total perception of family support, with 
responses rated on a Likert scale. The inventory was de-
veloped by Baptista24 and consists of 42 items and scores 
ranging from 0 to 84 points, with high scores indicating 
strong perception of family support, appraised on three 
dimensions: family adaptation; family affectivity, and fam-
ily autonomy. The instrument was validated for Brazilian 
college students, outpatient population, prisoners, and 
individuals with AOD dependence.24 In construct validity 
studies, Baptista24 used a principal components analysis 
with oblimin rotation and found 3 factors, explaining 
41.43% of variance with the following number of items, 
respectively: 21, 13, and 8. The Cronbach’s α values in our 
sample were very similar to those reported by the authors 
of the original instrument,24 considering the total score as 
well as the three dimensions. The following values were 
obtained in our sample and in the instrument manual, 
respectively: 0.96/0.93 regarding the “total FSPI score”; 
0.89/0.87 regarding “family adaptation score”; 0.94/ 
0.92 regarding “family affectivity score”; and 0.85/0.85 
regarding “family autonomy score”. 
 f) Criteria for substance abuse or dependence (DSM-IV): 
Immediately after the questionnaire and inventory ap-
plication to the volunteers, a psychologist completed a 
checklist of the nine DSM-IV criteria in order to determine 
the presence of abuse or dependence on alcohol or other 
drugs, according to the DSM-IV manual directions.3
Procedures
A psychologist explained to the patients how to answer the 
self-administered instruments, emphasizing that there were no 
“right” or “wrong” answers and that their answers would be 
kept strictly confidential. The application took place in a room 
with eight to twelve volunteers or patients. There was no time 
limitation for the participants to answer the questionnaires and 
inventories. On average, it took them 35-40 minutes to com-
plete the instruments. Subsequently, in an isolated place, the 
researcher completed the DSM-IV checklist on an individual basis 
Statistical analysis
The sociodemographic characteristics and previous treatment 
history of the group of patients with alcohol or drug depen-
dence were compared with those from the control group by 
Student’s t tests (for continuous variables with normal distri-
bution) or χ2 tests (for categorical variables). The BAI, BHS, 
BDI, and FSPI (total and adaptation, affectivity and autonomy 
dimensions) scores of the group of patients with alcohol or 
drug dependence were compared with those from the control 
group by Mann-Whitney U tests (for numeric variables without 
normal distribution). Spearman’s correlation coefficients were 
calculated between the scores of depression, anxiety, hope-
lessness, and family subscales scores for each group. A logistic 
regression analysis (logit) was used to estimate the odds ratio 
of being classified as “control group” (reference group = 0) or 
alcohol/drug dependent group (1). The independent variables 
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included in the model were: gender, schooling, income, psy-
chiatric treatment and the raw scores in the Beck inventories 
of depression, anxiety and hopelessness, as well as the FSPI 
scores (total and autonomy, affectivity and adaptation di-
mensions scores). We also used a correspondence analysis to 
assess the relationship between the studied variables, which 
showed statistical significance in the univariate analysis. In 
order to represent the association between variables, a 2-di-
mensional graphic representation of the multidimensional χ2 
distances is presented including the variables: BAI, BHS, and 
BDI and membership (AOD or control). Another similar analysis 
included family support scores (total and three dimensions: 
family adaptation; family affectivity, and family autonomy) 
and membership (AOD or control). The level of significance 
was set at 5%. All other statistical analyses were performed 
using the software Statistica®.
Results
Table 1 shows social and demographic data of the alcohol or 
drug dependent and control groups. They were similar regard-
ing age, educational level, and income. AOD group reported 
having undergone psychiatric treatment with a significantly 
higher frequency. The main drugs used by the AOD group 
were alcohol (35%), cocaine (21.7%), crack (36.7%), cannabis 
(3.33%), and other drugs (3.4%). 
Figure 1 shows the average scores on depression (BDI), 
anxiety (BAI) and hopelessness (BHS), as well as the average 
scores in the dimensions of family support in the control and 
AOD groups. Regarding Beck Depression Inventory (BDI), Beck 
Hopelessness Scale (BHS) ,and Beck Anxiety Inventory (BAI), 
the average scores of the control group were within the 
standard range for the non-clinical Brazilian population, as re-
ported in the Portuguese version of the manual.17 However, the 
average scores on BDI, BHS, and BAI from the alcohol or drug 
dependent group were significantly higher than those from 
the control group (BDI, U = 1,411; p < 0.0001; BAI, U = 1,236; 
p < 0.0001; BHS, U = 1,324; p < 0.0001). Regarding the ”total 
perception” dimension of FSPI, the alcohol or drug dependent 
group differed from the control group, indicating lower per-
ception of family support (U = 0.000; p < 0.0001). Similarly, the 
alcohol or drug dependent group presented lower scores in the 
specific dimensions family adaptation (U = 38.50; p < 0.0001), 
family affectivity (U = 46.50; p < 0.0001), and family autonomy 
(U = 145.5; p < 0.0001) than the control group.
Table 2 shows that in the alcohol or drug dependent 
group, but not in the control group, significant negative cor-
relations were found between the scores of family support 
(total and specific dimensions) and the scores of depression, 
anxiety or hopelessness. 
Similarly, we also found negative correlations between 
family adaptation and scores of anxiety, as well as be-
tween family affectivity and scores of depression or hope-
lessness. The Family Support Perception Inventory “total 
score” (sum of the partial scores of the specific dimensions: 
family adaptation, family affectivity, and family autonomy) 


























































Part A: Average scores (mean and SD) of the Beck Depression Inventory (BDI), 
Beck Anxiety Inventory (BAI), and Beck Hopelessness Scale (BHS) in control 
() and alcohol or drug dependent () groups. 
Part B: Average scores (mean and SD) of the specific dimensions (adaptation, 
affectivity, and autonomy) and total score of the Family Support Perception 
Inventory (FSPI) in the control () and alcohol or drug dependent () groups.
Figure 1 Average scores on depression,anxiety, hopelessness 
(A), and family support in the control and AOD groups (B).
Table 1  Social and demographic characteristics of people 
with alcohol or drug dependence (AOD) and non-dependent 
volunteers (control group). Data expressed as percentages 








Age [mean (SD)] 34 (10) 35 (11) t = 0.6679
df = 123
0.50








Higher - incomplete 5 3
Higher (complete) 13 11
Income (%)
up to US$ 200/month 54 57 χ2 = 0.6620
df = 2
0.71
US$ 420 - 840/month 28 22
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Table 2  Correlations (Spearman (rs) coefficients) 
between scores of depression (BDI), anxiety (BAI), 
hopelessness (BHS), and family support (FPSI total and 
autonomy, adaptation and affectivity dimensions) in 
the control group and in the alcohol or other drugs 
dependent group
BDI score BAI score BHS score
Control group
Family autonomy -0.02 -0.05 -0.05
Family adaptation -0.00 -0.00 -0.02
Family affectivity -0.06 -0.01 -0.07
Total family support -0.22 -0.06 -0.02
Alcohol and/or drug dependents
Family autonomy -0.43* -0.31* -0.38*
Family adaptation -0.59* -0.74* -0.50*
Family affectivity -0.62* -0.70* -0.62*
Total family support -0.80* -0.83* -0.72*
* In bold: significant Spearman’s correlation coefficients (p <.01).
 High scores in Beck Inventories indicate severity and high scores in FSPI 
dimensions indicate good family support.
over 77 and all subjects with alcohol or drug dependence 
scored under 78). Total score presented a high correlation 
(r = 0.96) with the scores of the family affectivity dimen-
sion, as well as with those from the family adaptation and 
family autonomy dimensions (r > 0.90). The final logistic 
regression model presented a significant goodness-of-fit 
(Maximum likelihood (MS-err. scaled to 1); Final loss: 14,4979, 
Chi²(9) = 144.09, p < 0.0001), considering as independent sig-
nificance variables: the BAI (anxiety) scores; the autonomy 
dimension of the Family Support Perception Inventory (FSPI) 
scores, and previous psychiatric treatment. 
This analysis included data from subjects of the control 
group (n = 65) and AOD group (n = 60). Other variables in-
cluded in the model, such as the scores of Beck Depression 
Inventory scores and Beck Hopelessness Scale, in addition 
to gender, age, education level, and income did not reach 
statistical significance (Table 3).
Table 4 shows the distribution of subjects classified ac-
cording to their scores in the Family Support Perception 
Inventory, levels of anxiety, hopelessness, and depression in 
the control (CON) and alcohol/drug dependent (AOD) groups. 
Figure 2 shows the correspondence analysis graphics, 
illustrating the relationship among the variables included 
in the analysis. We identified two different profiles among 
subjects. Correspondence analysis showed that low scores 
in the family support perception, as well as high levels of 
depression, anxiety, and hopelessness were associated with 
being part of the AOD group. On the other hand, low levels 
of anxiety, depression, hopelessness, and high level of fam-
ily support perception were associated with no use of AOD.
Discussion
In this study, we observed that feelings of hopelessness and 
negative perception of family support (in general, as well 
as in its dimensions: affectivity, autonomy, and adapta-
tion) were significantly higher in the AOD group than in the 
control group. This higher frequency of low perception of 
family support among subjects with alcohol or other drugs 
dependence compared to controls may reflect the family and 
social stigmatization of these patients. These processes of 
stigmatization or rejection of the patient by the family may 
be a consequence of substance use-related problems. On the 
other hand, the low family support may also be a vulnerability 
factor for the development of substance dependence. Our 
data suggest that the Family Support Perception Inventory 
scores could be a useful ‘social marker’ to discriminate 
Table 3  Logistic regression analysis to estimate the odds of 
group membership (dependent variable: control group = 0, 
N = 65, and alcohol or drug dependence group = 1, N = 60)
Variables OR (95% CI) p
Gender
control 1
alcohol/drug dependence 0.26 (0.01-6.78) 0.41
Age
control 1
alcohol/drug dependence 1.12 (0.98-1.28) 0.08
Educational level
control 1
alcohol/drug dependence 0.60 (0.16-14) 0.42
Income
control 1
alcohol/drug dependence 1.19 (0.50-2.81) 0.67
Previous psychiatric treatment
control 1
alcohol/drug dependence 68.91 (1.05-7.40) 0.001
BAI score
control 1
alcohol/drug dependence 1.22 (1.02 - 1.45) 0.001
BDI score
control 1
alcohol/drug dependence 0.94 (0.81-109) 0.46
BHS score
control 1
alcohol/drug dependence 0.64 (0.38-1.07) 0.09
FSPI adaptation dimension score
control 1
alcohol/drug dependence 2.88 (0.89-1.79) 0.76
FSPI autonomy dimension score
control 1
alcohol/drug dependence 0.08 (0.01-0.46) 0.001
FSPI affectivity dimension score
control 1
alcohol/drug dependence 3.68 (0.21-6.12) 0.79
FSPI total
control 1
alcohol/drug dependence 1.65 (0.99-8.19) 0.62
OR: odds ratio (unit change); CI: confidence interval.
Model: Logistic regression (logit) Loss: Max likelihood (MS-err. scaled to 1) 
Final loss: 14.49
Chi²(9) = 144,0; p < 0,0001. 
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Table 4  Percentage of subjects classified according to family support perception, levels of anxiety, hopelessness, and 




































































Control 0 0 0 0 27.0 29.7 32.4 10.8 45.9 10.8 8.1 35.1
AOD 13.5 5.4 35.1 45.9 27.0 29.7 32.4 10.8 45.9 10.8 8.1 35.1
Middle Low
Control 0 0 0 0 93.7 6.2 0 0 87.5 6.2 0 6.2
AOD 81.2 6.2 12.5 0 6.2 0 0 6.2 87.5 6.2 0 6.2
Middle High
Control 0 0 0 0 0 0 0 0 100 0 0 0
AOD 100 0 0 0 0 0 0 0 100 0 0 0
High
Control 92.3 7.7 0 0 23.0 1.5 1.5 23.0 92.3 7.6 0 0
AOD 100 0 0 0 0 0 0 0 100 0 0 0
Note: According to the Brazilian version, based on applications to general population Brazilian samples, the Beck scales cut-offs are respectively: BDI: 0-11 
minimal; 12-19 mild; 20-35 moderate; 36-63 severe depression; BAI 0 -10: minimal; 11 -19: mild; 20-30: moderate; and 31-63: severe anxiety; BHS 0-4 
minimal; 5-8 mild; 9-13 moderate; 14-20 severe hopelessness. The FSPI (total) cut-offs are: 0-53 low, 54-63 middle low, 64-70 middle high, 71-84 high, and 
the dimensions: family adaptation, family affectivity, and family autonomy.
were significantly related to the high rates of suicidal be-
havior in that population. However, as mentioned by Blume 
et al.28 the nature of the relationship between alcohol use 
and hopelessness is not clear and deserves further investi-
gation. According to other authors, alcohol or drug abusers 
may experience feelings of hopelessness due to alterations 
in serotonin (5HT) levels, one of the main neurotransmitters 
responsible for mood states control.29,30 They suggest that 
depression may be related to drug abuse because repeated 
administration of psychoactive substances may cause brain 
people with alcohol or drug dependence with co-morbidities 
from non-dependent ones.
The high levels of anxiety, depression, and hopelessness 
observed in the AOD group are in accordance with previous 
studies on psychiatric comorbidity.25,26 According to Sumnall 
et al.,27 anxiety or depression are predictors for drug abuse 
rather than drug abuse being the cause of these disorders. 
In our study, the use of alcohol and illicit drugs was also 
related to hopelessness. According to Alegría et al.,26 the 
high scores of hopelessness found in alcohol or drug users 
Part A On the left side of the figure, we observe an association (represented by the ellipse) between being part of the control group and to present minimal, 
mild, moderate or severe scores in the BAI, BDI, and BHS scales. On the right side, we observe an association between being an AOD and moderate or high 
scores (indicating high severity) of BHS, BDI, and BAI scores. (Correspondence analysis Cronbach’s α = 0.97). 
Part B Two different profiles are also observed among participants. The first group (on the left side of the figure)  represents AOD dependence, with low 
or middle-low scores in the total FSPI, family adaptation, family affectivity, family autonomy. The second group (on the right side of the figure) represents 
individuals from the control group with high or middle-high scores of total FSPI, adaptation, family affectivity, family autonomy. (Correspondence analysis 
Cronbach’s α = 0.95).
Figure 2 Correspondence analysis graphic illustrating the relationship between pertaining to the alcohol and other drugs 
problematic users group (AOD) or to the control group (CONTROL) and anxiety (BAI), depression (BDI), and hopelessness (BHS) 
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structural or functional alterations and down-regulate 
the mesolimbic dopaminergic activity in reward systems, 
facilitating the development of depression.31 Nurnberger 
et al.32 reported that “… the aggregation of antisocial 
personality disorder, drug dependence, anxiety disorders, 
and mood disorders suggests common mechanisms for these 
disorders and alcohol dependence within some families”. 
The presence of such disorders probably contributes to a 
poor relationship among family members, which may be 
expressed in low scores in the Family Support Perception 
Inventory. Alcohol or drug abuse related-problems may 
also disturb interpersonal relationships and social sup-
port. Furthermore, there is high risk of affective disorders 
development in those who have experienced adversities 
in childhood, such as lack of affection, traumas or abuse 
events, inadequate social support, broken families, and 
parents with high levels of alcohol consumption.33 There is 
also compelling evidence that many alcohol or drug abus-
ers have been through several similar negative experiences 
such as those above mentioned, mainly at an early age.34 
There is also evidence that family and psychosocial 
problems contribute to trigger mental disorders, such as 
depression, anxiety, traumatic events, and childhood abuse. 
Edwards et al.35 reported an association between symptoms 
of traumatic stress and substance abuse, considering that 
traumatic stress symptoms may lead to substance use in 
order to cope with them. Additionally, Gonzalez et al.36 
reported problematic alcohol use among students with 
elevated depression. The authors considered that this can 
be partly attributed to drinking to cope, as well as to the 
association of depression with negative urgency. Tucci et al.34 
found a significant association between childhood trauma 
and a higher prevalence of psychiatric comorbidities (such 
as substance use and depression) compared to a controlled 
sample without childhood abuse or neglect. Carrigan et al.37 
reported that repeated alcohol use may be a coping strategy 
to reduce anxiety and tension in social occasions. On the 
other hand, a good family support has been related to low 
prevalence of symptoms of anxiety and depression, and has 
a positive influence on psychotherapeutic treatment for 
mood disorders.21 Some authors suggested that the reasons 
for young people and adults to cease alcohol or drug use 
were frequently related to the availability of information 
and protective family structures.38 Considering its social 
related consequences, alcohol or drug abuse or dependence 
may be considered a family problem that requires approach 
of all family members as an important part of diagnosis 
and treatment.39 Family support may be of extreme help in 
the recovery of alcohol or drug abusers and it is related to 
treatment success.40 Family members’ participation in the 
treatment contributes to the achievement of treatment goals 
and the monitoring of dependents, significantly improving 
the outcome.41
Conclusions
In summary, we found a significant association between low 
family support and high scores of depression, anxiety, and 
hopelessness in alcohol or other drug dependents, but not in 
the control group. Thus, our data strengthen the importance 
of family support as a protective factor against alcohol or 
drug abuse or dependence and lack of family support as a 
possible vulnerability factor. It also stress the importance of 
assessing and taking into account the family support for an 
adequate planning of treatment interventions. The family 
involvement during treatment may decrease the feelings 
of lack of support and hopelessness, increasing the rates of 
adherence to treatment and recovery of alcohol or drug de-
pendents. We also showed that the Family Support Perception 
Inventory was a sensitive tool to differentiate people with 
alcohol or drug dependence from a non-dependent control 
group, suggesting that it could be tested as a kind of indirect, 
‘social marker’ of substance abuse or dependence, prevent-
ing problems of stigmatization presented by very specific 
screening instruments. 
Although our data analysis suggests that the family sup-
port perception instrument might be a useful screening tool 
to detect people with alcohol or other drug-related problems, 
further studies are needed including a sample of people 
with “moderate” or “risky use” of alcohol and other drugs. 
A limitation of this study is the fact that our samples were 
composed of individuals with “extreme profiles”: a control 
group comprising only occasional AOD users compared with 
a group of dependent drug users. 
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